A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

May 23, 2023

Study Completion Date

May 23, 2023

Conditions
MigraineEpisodic Migraine
Interventions
DRUG

Galcanezumab

Administered SC.

DRUG

Rimegepant

Administered orally.

DRUG

Placebo

Administered orally.

DRUG

Placebo

Administered SC.

Trial Locations (77)

14226

Dent Neurosciences Research Center (Research Facility), Amherst

14609

Rochester Clinical Research, Inc., Rochester

23502

Alliance for Multispecialty Research, LLC - AMR Norfolk, Norfolk

27607

North Carolina Clinical Research, Raleigh

29405

Coastal Carolina Research Center, North Charleston

29607

Tribe Clinical Research, LLC, Greenville

29650

Premier Neurology Research, P.C., Greer

30265

Better Health Clinical Research, Newnan

30329

DelRicht Research, Atlanta

31406

Meridian Clinical Research, Savannah

32720

Accel Research Sites- Clinical Research Unit, DeLand

33009

Velocity Clinical Research, Hallandale Beach, Hallandale

33134

AMR Miami, Coral Gables

33176

Visionary Investigators Network, Miami

33180

Visionary Investigators Network, Miami

33409

Palm Beach Research Center, West Palm Beach

33612

University of South Florida, Tampa

33756

Innovative Research of West Florida, Clearwater

33803

Accel Research Sites-LKD CRU, Lakeland

34761

Sensible Healthcare, LLC, Ocoee

37203

Clinical Research Associates, Nashville

37920

Alliance for Multispecialty Research, LLC, Knoxville

39503

MedPharmics, LLC, Gulfport

40213

L-MARC Research Center, Louisville

40509

Alliance for Multispecialty Research, LLC Lexington, Lexington

44718

NeuroScience Research Center, LLC, Canton

45459

Dayton Center for Neurological Disorders, Centerville

Neurology Diagnostics, Inc., Dayton

46123

American Health Network of Indiana, LLC - Avon, Avon

47713

Deaconess Clinic, Evansville

48098

Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy

48104

Michigan Headache & Neurological Institute, Ann Arbor

60657

Chicago Headache Center, Chicago

63042

Healthcare Research Network - St. Louis, Hazelwood

67042

Alliance for Multispecialty Research, LLC El Dorado, El Dorado

70124

DelRicht Research, New Orleans

70433

DelRicht Research, Covington

70769

DelRicht Research, Prairieville

73013

Tekton Research, Edmond

73072

Lynn Institute of Norman, Norman

73099

Tekton Research, Yukon

73112

Lynn Health Science Institute, Oklahoma City

74133

DelRicht Research, Tulsa

75010

ACRC Trials, Carrollton

75024

ACRC Trials, Plano

76104

Ventavia Research Group, Fort Worth

76248

Ventavia Research Group - Keller, Keller

77064

Dynamed Clinical Research, LP d/b/a DM Clinical Research, Humble

77065

Accurate Clinical Management - Houston, Houston

78613

Velocity Clinical Research, Austin, Cedar Park

78705

Tekton Research (Research Facility), Austin

78731

FutureSearch Trials of Neurology, Austin

78735

ACRC Trials, Austin

84015

Alpine Research Organization, Clinton

84088

Advanced Clinical Research, West Jordan

85044

Foothills Research Center / CCT Research, Phoenix

85281

Alliance for Multispecialty Research, LLC Tempe, Tempe

85297

Gilbert Neurology, Gilbert

87102

Albuquerque Clinical Trials, Inc., Albuquerque

89119

Alliance for Multispecialty Research, LLC, Las Vegas

90067

California Medical Clinic for Headache and The Los Angeles Headache Center (Research Facility), Los Angeles

91316

Wr- Pri, Llc, Encino

91606

Velocity Clinical Research, North Hollywood, North Hollywood

91911

Velocity Clinical Research, Chula Vista, Chula Vista

91942

Velocity Clinical Research, San Diego, La Mesa

91978

Encompass Clinical Research, Spring Valley

92374

Anderson Clinical Research, Redlands

92660

Pharmacology Research Institute, Newport Beach

92704

Velocity Clinical Research, Huntington Park, Santa Ana

95823

Center for Clinical Trials of Sacramento, Sacramento

97504

Velocity Clinical Research - Medford, Medford

97527

Velocity Clinical Research, Grants Pass (Research Facility), Grants Pass

98007

Northwest Clinical Research Center, Bellevue

99202

Velocity Clinical Research, Banning, Banning

06517

CMR of Greater New Haven, LLC, Hamden

02131

Boston Clinical Trials, Boston

02818

Velocity Clinical Research, Providence, East Greenwich

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT05127486 - A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine | Biotech Hunter | Biotech Hunter